JP2006520761A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520761A5
JP2006520761A5 JP2006504337A JP2006504337A JP2006520761A5 JP 2006520761 A5 JP2006520761 A5 JP 2006520761A5 JP 2006504337 A JP2006504337 A JP 2006504337A JP 2006504337 A JP2006504337 A JP 2006504337A JP 2006520761 A5 JP2006520761 A5 JP 2006520761A5
Authority
JP
Japan
Prior art keywords
alkyl
use according
compound
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006504337A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2004/000205 external-priority patent/WO2004084876A2/en
Publication of JP2006520761A publication Critical patent/JP2006520761A/ja
Publication of JP2006520761A5 publication Critical patent/JP2006520761A5/ja
Withdrawn legal-status Critical Current

Links

JP2006504337A 2003-03-26 2004-03-25 薬物誘発性細胞毒性の予防のための化合物の使用 Withdrawn JP2006520761A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300459 2003-03-26
PCT/DK2004/000205 WO2004084876A2 (en) 2003-03-26 2004-03-25 Use of compounds for the prevention of drug-induced cell toxicity

Publications (2)

Publication Number Publication Date
JP2006520761A JP2006520761A (ja) 2006-09-14
JP2006520761A5 true JP2006520761A5 (https=) 2007-04-19

Family

ID=58707224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006504337A Withdrawn JP2006520761A (ja) 2003-03-26 2004-03-25 薬物誘発性細胞毒性の予防のための化合物の使用

Country Status (11)

Country Link
US (1) US20070004727A1 (https=)
EP (1) EP1610773A2 (https=)
JP (1) JP2006520761A (https=)
CN (1) CN100441175C (https=)
AU (1) AU2004224788A1 (https=)
BR (1) BRPI0408699A (https=)
CA (1) CA2560522A1 (https=)
EA (1) EA200501518A1 (https=)
MX (1) MXPA05010143A (https=)
WO (1) WO2004084876A2 (https=)
ZA (1) ZA200508482B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006037335A2 (en) * 2004-10-06 2006-04-13 Recepticon Aps Use of compounds for the prevention of drug-induced cell toxicity
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (en) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
WO2012151555A1 (en) * 2011-05-04 2012-11-08 President And Fellows Of Harvard College Methods and coatings for treating biofilms
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
WO2020108753A1 (en) * 2018-11-28 2020-06-04 ITM Isotopen Technologien München AG Novel tumor antigen binding agents and uses thereof
CN115003311B (zh) * 2019-12-14 2024-04-19 乔杜里·马努 降低多器官毒性的多元药物制剂
JP2024506999A (ja) * 2021-02-02 2024-02-15 コン，ヤンピン がんを処置するための組成物および方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1364521A (en) * 1971-07-16 1974-08-21 Merck & Co Inc Aminoglycoside antibiotics
US4564325A (en) * 1983-03-14 1986-01-14 Ackerman Galen R Flush-mounted round bale mover for truck beds
US4654325A (en) * 1984-05-24 1987-03-31 Selenke William M Medicament for reducing nephrotoxicity caused by positively charged agents such as aminoglycosides and methods of use thereof
AU629533B2 (en) * 1987-12-22 1992-10-08 U.S. Bioscience, Inc. Improving toxicity profiles in chemotherapy
US5010092A (en) * 1989-12-22 1991-04-23 Wisconsin Alumni Research Foundation Protection against chemically-induced kidney damage by methimazole
US5039666A (en) * 1990-10-30 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside
US5409915A (en) * 1993-09-14 1995-04-25 The University Of Vermont And State Agricultural College Bis-platinum (IV) complexes as chemotherapeutic agents
US5658902A (en) * 1994-12-22 1997-08-19 Warner-Lambert Company Quinazolines as inhibitors of endothelin converting enzyme
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents
WO1999002145A1 (en) * 1997-07-07 1999-01-21 Cambridge Neuroscience, Inc. Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines
US6177434B1 (en) * 1997-12-16 2001-01-23 The United States Of America As Represented By The Secretary Of The Navy Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
US6949679B1 (en) * 1998-04-21 2005-09-27 Universite Laval Polyamine transport inhibitors
FR2797444B1 (fr) * 1999-08-13 2003-02-07 Lafon Labor Compositions pharmaceutiques comprenant des 4-quinolones
DE10053506A1 (de) * 2000-10-27 2002-05-02 Max Delbrueck Centrum Mittel zur Prävention von Organschäden, die durch Aminoglykoside induziert werden
CN100582084C (zh) * 2001-01-08 2010-01-20 麦迪凯斯特治疗学股份有限公司 疏水性多胺类似物及其使用方法
US20050027016A1 (en) * 2002-02-07 2005-02-03 Fahl Kathleen L Polyamine compounds and compositions for use in conjection with cancer therapy
AU2002307802A1 (en) * 2002-04-25 2003-10-08 Recepticon Aps Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents

Similar Documents

Publication Publication Date Title
JP2006520761A5 (https=)
JP2007517807A5 (https=)
JP2006503082A5 (https=)
JP2012508252A5 (https=)
JP2009536620A5 (https=)
MY144655A (en) Pyrimidine urea derivatives as kinase inhibitors
CA2503868A1 (en) Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
JP2010509356A5 (https=)
JP2011505347A5 (https=)
JP2007511504A5 (https=)
CA2545427A1 (en) Selective kinase inhibitors
JP2006501201A5 (https=)
JP2011504903A5 (https=)
RU2006126974A (ru) Амидное производное и лекарственное средство
WO2005047279A8 (en) Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
JP2006523214A5 (https=)
JP2007523177A5 (https=)
JP2012533601A5 (https=)
EP2266969A3 (en) 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
CA2451241A1 (en) Unsymmetrical cyclic diamine compound
RU2006139644A (ru) Новые растворимые в воде пролекарства
RU2441021C2 (ru) Лизобактинамиды
JP2003516975A5 (https=)
US20140243327A1 (en) Riminophenazines with 2-(heteroaryl) amino substituents and their anti-microbial activity